These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17632511)

  • 21. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental origin, functional maintenance and genetic rescue of osteoclasts.
    Jacome-Galarza CE; Percin GI; Muller JT; Mass E; Lazarov T; Eitler J; Rauner M; Yadav VK; Crozet L; Bohm M; Loyher PL; Karsenty G; Waskow C; Geissmann F
    Nature; 2019 Apr; 568(7753):541-545. PubMed ID: 30971820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopetrosis: genetics, treatment and new insights into osteoclast function.
    Sobacchi C; Schulz A; Coxon FP; Villa A; Helfrich MH
    Nat Rev Endocrinol; 2013 Sep; 9(9):522-36. PubMed ID: 23877423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts.
    Stattin EL; Henning P; Klar J; McDermott E; Stecksen-Blicks C; Sandström PE; Kellgren TG; Rydén P; Hallmans G; Lönnerholm T; Ameur A; Helfrich MH; Coxon FP; Dahl N; Wikström J; Lerner UH
    Sci Rep; 2017 Jun; 7(1):3012. PubMed ID: 28592808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.
    Taranta A; Migliaccio S; Recchia I; Caniglia M; Luciani M; De Rossi G; Dionisi-Vici C; Pinto RM; Francalanci P; Boldrini R; Lanino E; Dini G; Morreale G; Ralston SH; Villa A; Vezzoni P; Del Principe D; Cassiani F; Palumbo G; Teti A
    Am J Pathol; 2003 Jan; 162(1):57-68. PubMed ID: 12507890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An SNX10 mutation causes malignant osteopetrosis of infancy.
    Aker M; Rouvinski A; Hashavia S; Ta-Shma A; Shaag A; Zenvirt S; Israel S; Weintraub M; Taraboulos A; Bar-Shavit Z; Elpeleg O
    J Med Genet; 2012 Apr; 49(4):221-6. PubMed ID: 22499339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteoporosis and RANKL signal].
    Nakamura M; Udagawa N
    Clin Calcium; 2011 Aug; 21(8):1149-55. PubMed ID: 21814019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal Stromal Cell-Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl-Deficient Osteopetrosis.
    Menale C; Campodoni E; Palagano E; Mantero S; Erreni M; Inforzato A; Fontana E; Schena F; Van't Hof R; Sandri M; Tampieri A; Villa A; Sobacchi C
    Stem Cells Transl Med; 2019 Jan; 8(1):22-34. PubMed ID: 30184340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in the understanding of the pathophysiology of osteopetrosis.
    Felix R; Hofstetter W; Cecchini MG
    Eur J Endocrinol; 1996 Feb; 134(2):143-56. PubMed ID: 8630510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
    Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
    J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A missense mutation sheds light on a novel structure-function relationship of RANKL.
    Qiu H; Qin A; Cheng T; Chim SM; Smithers L; Chen K; Song D; Liu Q; Zhao J; Wang C; Teguh D; Zhang G; Tickner J; Vrielink A; Pavlos NJ; Xu J
    J Cell Physiol; 2021 Apr; 236(4):2800-2816. PubMed ID: 32964459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.
    Cappariello A; Berardi AC; Peruzzi B; Del Fattore A; Ugazio A; Bottazzo GF; Teti A
    J Bone Miner Res; 2010 Jan; 25(1):106-13. PubMed ID: 20091929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel mutation in RANKL by whole-exome sequencing in a Thai family with osteopetrosis; a case report and review of RANKL osteopetrosis.
    Lertwilaiwittaya P; Suktitipat B; Khongthon P; Pongsapich W; Limwongse C; Pithukpakorn M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1727. PubMed ID: 34056870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in osteoclast biology resulting from the study of osteopetrotic mutations.
    Segovia-Silvestre T; Neutzsky-Wulff AV; Sorensen MG; Christiansen C; Bollerslev J; Karsdal MA; Henriksen K
    Hum Genet; 2009 Jan; 124(6):561-77. PubMed ID: 18987890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
    Sharma SM; Sif S; Ostrowski MC; Sankar U
    J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.
    Chen W; Twaroski K; Eide C; Riddle MJ; Orchard PJ; Tolar J
    J Bone Joint Surg Am; 2019 Nov; 101(21):1939-1947. PubMed ID: 31567691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopetroses and immunodeficiencies in humans.
    Villa A; Vezzoni P; Frattini A
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):421-7. PubMed ID: 17088646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.